Semin Thromb Hemost 2016; 42(06): 603-611
DOI: 10.1055/s-0036-1581100
Review Article
Thieme Medical Publishers 333 Seventh Avenue, New York, NY 10001, USA.

Venous Thromboembolism in Children: Is It Preventable?

Tina T. Biss
1   Department of Haematology, The Newcastle upon Tyne Hospitals NHS Foundation Trust, Newcastle upon Tyne, United Kingdom
› Author Affiliations
Further Information

Publication History

Publication Date:
06 June 2016 (online)

Abstract

The incidence of venous thromboembolism (VTE) in children is increasing. Hospitalized infants and adolescents are at highest risk, and most individuals who have VTE have multiple thrombotic risk factors. The presence of a central venous catheter (CVC) is the most frequent risk factor for childhood thrombosis. Childhood VTE has significant consequences in relation to the thrombotic event and the anticoagulant therapy used for its treatment. Identification of the most prevalent risk factors for VTE, particularly among adolescents, has moved the focus toward prevention of thrombosis. Risk assessment models have been developed to identify individuals who are at higher risk with a view to employing preventative strategies such as mechanical and chemical thromboprophylaxis (TP). There is currently little evidence to support the efficacy of such strategies for preventing either CVC-associated thrombosis or thrombosis at other sites. In addition, there are concerns about adverse consequences of mechanical and chemical TP in a population where the overall incidence of VTE remains low.

 
  • References

  • 1 Andrew M, David M, Adams M , et al. Venous thromboembolic complications (VTE) in children: first analyses of the Canadian Registry of VTE. Blood 1994; 83 (5) 1251-1257
  • 2 van Ommen CH, Heijboer H, Büller HR, Hirasing RA, Heijmans HSA, Peters M. Venous thromboembolism in childhood: a prospective two-year registry in The Netherlands. J Pediatr 2001; 139 (5) 676-681
  • 3 Stein PD, Kayali F, Olson RE. Incidence of venous thromboembolism in infants and children: data from the National Hospital Discharge Survey. J Pediatr 2004; 145 (4) 563-565
  • 4 Raffini L, Huang YS, Witmer C, Feudtner C. Dramatic increase in venous thromboembolism in children's hospitals in the United States from 2001 to 2007. Pediatrics 2009; 124 (4) 1001-1008
  • 5 Gibson BES, Chalmers EA, Bolton-Maggs P, Henderson DJ, Lynn R. Thromboembolism in childhood: a prospective two-year BPSU study in the United Kingdom. February 2001–February 2003. Br J Haematol 2004; 25 (Suppl. 01) 1
  • 6 Biss T, Alikhan R, Payne J , et al. Venous thromboembolism occurring during adolescence. Arch Dis Child 2016; (e-pub ahead of print). doi:10.1136/archdischild-2015-309875
  • 7 Lippi G, Franchini M. Pathogenesis of venous thromboembolism: when the cup runneth over. Semin Thromb Hemost 2008; 34 (8) 747-761
  • 8 Massicotte MP, Dix D, Monagle P, Adams M, Andrew M. Central venous catheter related thrombosis in children: analysis of the Canadian Registry of Venous Thromboembolic Complications. J Pediatr 1998; 133 (6) 770-776
  • 9 Biss TT, Brandão LR, Kahr WH, Chan AK, Williams S. Clinical features and outcome of pulmonary embolism in children. Br J Haematol 2008; 142 (5) 808-818
  • 10 Ichord RN, Benedict SL, Chan AK, Kirkham FJ, Nowak-Göttl U ; International Paediatric Stroke Study Group. Paediatric cerebral sinovenous thrombosis: findings of the International Paediatric Stroke Study. Arch Dis Child 2015; 100 (2) 174-179
  • 11 Schmidt B, Andrew M. Neonatal thrombosis: report of a prospective Canadian and international registry. Pediatrics 1995; 96 (5, Pt 1): 939-943
  • 12 Monagle P, Chan AKC, Goldenberg NA , et al. Antithrombotic therapy in neonates and children: Antithrombotic Therapy and Prevention of Thrombosis, 9th ed: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines. Chest 2012; 141: e737S-e801S
  • 13 Chalmers E, Ganesen V, Liesner R , et al; British Committee for Standards in Haematology. Guideline on the investigation, management and prevention of venous thrombosis in children. Br J Haematol 2011; 154 (2) 196-207
  • 14 Monagle P, Adams M, Mahoney M , et al. Outcome of pediatric thromboembolic disease: a report from the Canadian Childhood Thrombophilia Registry. Pediatr Res 2000; 47 (6) 763-766
  • 15 Goldenberg NA, Donadini MP, Kahn SR , et al. Post-thrombotic syndrome in children: a systematic review of frequency of occurrence, validity of outcome measures, and prognostic factors. Haematologica 2010; 95 (11) 1952-1959
  • 16 Ruud E, Holmstrøm H, Hopp E, Wesenberg F. Central line-associated venous late effects in children without prior history of thrombosis. Acta Paediatr 2006; 95 (9) 1060-1065
  • 17 Hancock HS, Wang M, Gist KM , et al. Cardiac findings and long-term thromboembolic outcomes following pulmonary embolism in children: a combined retrospective-prospective inception cohort study. Cardiol Young 2013; 23 (3) 344-352
  • 18 deVeber G, Andrew M, Adams C , et al; Canadian Pediatric Ischemic Stroke Study Group. Cerebral sinovenous thrombosis in children. N Engl J Med 2001; 345 (6) 417-423
  • 19 Bruce AAK, Bauman ME, Black K, Newton A, Legge L, Massicotte MP. Development and preliminary evaluation of the KIDCLOT PAC QL: a new health-related quality of life measure for pediatric long-term anticoagulation therapy. Thromb Res 2010; 126 (2) e116-e121
  • 20 Jones S, Mertyn E, Alhucema P, Monagle P, Newall F. HEEADSSS assessment for adolescents requiring anticoagulation therapy. Arch Dis Child 2012; 97 (5) 430-433
  • 21 Qureshi A, Mitchell C, Richards S, Vora A, Goulden N. Asparaginase-related venous thrombosis in UKALL 2003- re-exposure to asparaginase is feasible and safe. Br J Haematol 2010; 149 (3) 410-413
  • 22 National Institute for Health and Clinical Excellence. Venous thromboembolism: reducing the risk of venous thromboembolism (deep vein thrombosis and pulmonary embolism) in patients admitted to hospital. NICE clinical guideline 92. 2010 . Available at: http://www.nice.org.uk/CG92 . Accessed January 30, 2016
  • 23 Vidal E, Sharathkumar A, Glover J, Faustino EVS. Central venous catheter-related thrombosis and thromboprophylaxis in children: a systematic review and meta-analysis. J Thromb Haemost 2014; 12 (7) 1096-1109
  • 24 Pierce CM, Wade A, Mok Q. Heparin-bonded central venous lines reduce thrombotic and infective complications in critically ill children. Intensive Care Med 2000; 26 (7) 967-972
  • 25 Anton N, Cox PN, Massicotte MP , et al. Heparin-bonded central venous catheters do not reduce thrombosis in infants with congenital heart disease: a blinded randomized, controlled trial. Pediatrics 2009; 123 (3) e453-e458
  • 26 McLean TW, Fisher CJ, Snively BM, Chauvenet AR. Central venous lines in children with lesser risk acute lymphoblastic leukemia: optimal type and timing of placement. J Clin Oncol 2005; 23 (13) 3024-3029
  • 27 Jaffray J, Dang K, Vasquez B , et al. The incidence of deep vein thrombosis in children with peripherally inserted central venous catheters versus tunneled centrally inserted catheters. J Thromb Haemost 2015; 13: PO439
  • 28 Male C, Julian JA, Massicotte P, Gent M, Mitchell L ; PROTEKT Study Group. Significant association with location of central venous line placement and risk of venous thrombosis in children. Thromb Haemost 2005; 94 (3) 516-521
  • 29 Male C, Chait P, Andrew M, Hanna K, Julian J, Mitchell L ; PARKAA Investigators. Central venous line-related thrombosis in children: association with central venous line location and insertion technique. Blood 2003; 101 (11) 4273-4278
  • 30 Handrup MM, Møller JK, Frydenberg M, Schrøder H. Placing of tunneled central venous catheters prior to induction chemotherapy in children with acute lymphoblastic leukemia. Pediatr Blood Cancer 2010; 55 (2) 309-313
  • 31 Barrera LM, Perel P, Ker K, Cirocchi R, Farinella E, Morales Uribe CH. Thromboprophylaxis for trauma patients. Cochrane Database Syst Rev 2013; 3: CD008303
  • 32 Handoll HH, Farrar MJ, McBirnie J, Tytherleigh-Strong G, Milne AA, Gillespie WJ. Heparin, low molecular weight heparin and physical methods for preventing deep vein thrombosis and pulmonary embolism following surgery for hip fractures. Cochrane Database Syst Rev 2002; (4) CD000305
  • 33 Lippi G, Favaloro EJ, Cervellin G. Prevention of venous thromboembolism: focus on mechanical prophylaxis. Semin Thromb Hemost 2011; 37 (3) 237-251
  • 34 Meier KA, Clark E, Tarango C, Chima RS, Shaughnessy E. Venous thromboembolism in hospitalized adolescents: an approach to risk assessment and prophylaxis. Hosp Pediatr 2015; 5 (1) 44-51
  • 35 Clarke M, da Cruz E, Koehler J, Kaufman J. A multicenter survey of heparin prophylaxis practice in pediatric critical care. J Intensive Care Med 2011; 26 (5) 314-317
  • 36 Schroeder AR, Axelrod DM, Silverman NH, Rubesova E, Merkel E, Roth SJ. A continuous heparin infusion does not prevent catheter-related thrombosis in infants after cardiac surgery. Pediatr Crit Care Med 2010; 11 (4) 489-495
  • 37 Mitchell L, Andrew M, Hanna K , et al. Trend to efficacy and safety using antithrombin concentrate in prevention of thrombosis in children receiving l-asparaginase for acute lymphoblastic leukemia. Results of the PAARKA study. Thromb Haemost 2003; 90 (2) 235-244
  • 38 Ruud E, Holmstrøm H, De Lange C, Hogstad EM, Wesenberg F. Low-dose warfarin for the prevention of central line-associated thromboses in children with malignancies—a randomized, controlled study. Acta Paediatr 2006; 95 (9) 1053-1059
  • 39 Massicotte P, Julian JA, Gent M , et al; PROTEKT Study Group. An open-label randomized controlled trial of low molecular weight heparin for the prevention of central venous line-related thrombotic complications in children: the PROTEKT trial. Thromb Res 2003; 109 (2–3) 101-108
  • 40 Andrew M, Marzinotto V, Pencharz P , et al. A cross-sectional study of catheter-related thrombosis in children receiving total parenteral nutrition at home. J Pediatr 1995; 126 (3) 358-363
  • 41 Newall F, Barnes C, Savoia H, Campbell J, Monagle P. Warfarin therapy in children who require long-term total parenteral nutrition. Pediatrics 2003; 112 (5) e386
  • 42 Vegting IL, Tabbers MM, Benninga MA , et al. Prophylactic anticoagulation decreases catheter-related thrombosis and occlusion in children with home parenteral nutrition. JPEN J Parenter Enteral Nutr 2012; 36 (4) 456-462
  • 43 Askegard-Giesmann JR, O'Brien SH, Wang W, Kenney BD. Increased use of enoxaparin in pediatric trauma patients. J Pediatr Surg 2012; 47 (5) 980-983
  • 44 Hanson SJ, Punzalan RC, Arca MJ , et al. Effectiveness of clinical guidelines for deep vein thrombosis prophylaxis in reducing the incidence of venous thromboembolism in critically ill children after trauma. J Trauma Acute Care Surg 2012; 72 (5) 1292-1297
  • 45 von Vajna E, Alam R, So TY. Current clinical trials on the use of direct oral anticoagulants in the pediatric population (e-pub ahead of print). Cardiol Ther 2016; doi:10.1007/s40119-015-0054-y
  • 46 Cavo M, Wang W, O'Brien SH. Use of low molecular weight heparin for thromboprophylaxis in a pediatric inpatient population: reasons for use and incidence of bleeding complications. Thromb Res 2010; 125 (4) 370-372
  • 47 Stem J, Christensen A, Davis D, Raffini L. Safety of prophylactic anticoagulation at a pediatric hospital. J Pediatr Hematol Oncol 2013; 35 (7) e287-e291
  • 48 Leonardi MJ, McGory ML, Ko CY. The rate of bleeding complications after pharmacologic deep venous thrombosis prophylaxis: a systematic review of 33 randomized controlled trials. Arch Surg 2006; 141 (8) 790-797 , discussion 797–799
  • 49 Azu MC, McCormack JE, Scriven RJ, Brebbia JS, Shapiro MJ, Lee TK. Venous thromboembolic events in pediatric trauma patients: is prophylaxis necessary?. J Trauma 2005; 59 (6) 1345-1349
  • 50 Truitt AK, Sorrells DL, Halvorson E , et al. Pulmonary embolism: which pediatric trauma patients are at risk?. J Pediatr Surg 2005; 40 (1) 124-127
  • 51 Vavilala MS, Nathens AB, Jurkovich GJ, Mackenzie E, Rivara FP. Risk factors for venous thromboembolism in pediatric trauma. J Trauma 2002; 52 (5) 922-927
  • 52 Hanson SJ, Punzalan RC, Greenup RA, Liu H, Sato TT, Havens PL. Incidence and risk factors for venous thromboembolism in critically ill children after trauma. J Trauma 2010; 68 (1) 52-56
  • 53 Sabharwal S, Passannante MR. Venous thromboembolism in children: preliminary results of a survey of POSNA members. J Pediatr Orthop 2013; 33 (8) 852-856
  • 54 Faustino EVS, Patel S, Thiagarajan RR, Cook DJ, Northrup V, Randolph AG. Survey of pharmacologic thromboprophylaxis in critically ill children. Crit Care Med 2011; 39 (7) 1773-1778
  • 55 Faustino EVS, Hanson S, Spinella PC , et al; PROphylaxis against ThRombosis prACTice (PROTRACT) Study Investigators of the PALISI BloodNet. A multinational study of thromboprophylaxis practice in critically ill children. Crit Care Med 2014; 42 (5) 1232-1240
  • 56 Atchison CM, Arlikar S, Amankwah E , et al. Development of a new risk score for hospital-associated venous thromboembolism in noncritically ill children: findings from a large single-institutional case-control study. J Pediatr 2014; 165 (4) 793-798
  • 57 Arlikar SJ, Atchison CM, Amankwah EK , et al. Development of a new risk score for hospital-associated venous thromboembolism in critically-ill children not undergoing cardiothoracic surgery. Thromb Res 2015; 136 (4) 717-722
  • 58 Sharathkumar AA, Mahajerin A, Heidt L , et al. Risk-prediction tool for identifying hospitalized children with a predisposition for development of venous thromboembolism: Peds-Clot clinical Decision Rule. J Thromb Haemost 2012; 10 (7) 1326-1334
  • 59 Jackson PC, Morgan JM. Perioperative thromboprophylaxis in children: development of a guideline for management. Paediatr Anaesth 2008; 18 (6) 478-487
  • 60 Raffini L, Trimarchi T, Beliveau J, Davis D. Thromboprophylaxis in a pediatric hospital: a patient-safety and quality-improvement initiative. Pediatrics 2011; 127 (5) e1326-e1332
  • 61 Mitchell L, Lambers M, Flege S , et al. Validation of a predictive model for identifying an increased risk for thromboembolism in children with acute lymphoblastic leukemia: results of a multicenter cohort study. Blood 2010; 115 (24) 4999-5004